A detailed history of Novo Holdings transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Novo Holdings holds 2,500,000 shares of FOLD stock, worth $24 Million. This represents 1.87% of its overall portfolio holdings.

Number of Shares
2,500,000
Previous 2,500,000 -0.0%
Holding current value
$24 Million
Previous $24.8 Million 7.66%
% of portfolio
1.87%
Previous 1.77%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$9.97 - $14.52 $4.03 Million - $5.87 Million
404,100 Added 19.28%
2,500,000 $35.5 Million
Q4 2022

Feb 14, 2023

SELL
$9.89 - $12.7 $40,549 - $52,070
-4,100 Reduced 0.2%
2,095,900 $25.6 Million
Q3 2022

Nov 14, 2022

SELL
$9.82 - $12.75 $5.25 Million - $6.82 Million
-535,000 Reduced 20.3%
2,100,000 $21.9 Million
Q2 2022

Aug 15, 2022

BUY
$6.23 - $11.12 $465,935 - $831,653
74,789 Added 2.92%
2,635,000 $28.3 Million
Q3 2021

Nov 15, 2021

BUY
$8.74 - $11.84 $4.91 Million - $6.66 Million
562,331 Added 28.15%
2,560,211 $24.5 Million
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $304,850 - $375,200
35,000 Added 1.78%
1,997,880 $19.3 Million
Q1 2021

May 17, 2021

BUY
$9.2 - $23.86 $2.56 Million - $6.64 Million
278,085 Added 16.51%
1,962,880 $19.4 Million
Q4 2020

Feb 16, 2021

SELL
$13.47 - $24.89 $8.56 Million - $15.8 Million
-635,231 Reduced 27.38%
1,684,795 $38.9 Million
Q1 2020

May 15, 2020

BUY
$6.63 - $11.16 $14,294 - $24,060
2,156 Added 0.09%
2,320,026 $21.4 Million
Q2 2019

Aug 14, 2019

BUY
$10.96 - $14.4 $4.93 Million - $6.48 Million
450,000 Added 24.09%
2,317,870 $28.9 Million
Q4 2018

Feb 14, 2019

BUY
$8.38 - $13.44 $1.84 Million - $2.96 Million
220,000 Added 13.35%
1,867,870 $17.9 Million
Q3 2018

Nov 14, 2018

BUY
$11.6 - $16.54 $6.57 Million - $9.37 Million
566,689 Added 52.41%
1,647,870 $0
Q2 2018

Aug 14, 2018

BUY
$13.13 - $17.09 $14.2 Million - $18.5 Million
1,081,181 New
1,081,181 $16.9 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.69B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.